Biologics Outsourcing Market
According to Intent Market Research, the Biologics Outsourcing Market is expected to grow from USD 17.6 billion in 2023 at a CAGR of 15.2% to touch USD 47.3 billion by 2030. The Biologics Outsourcing Market is dominated by key players such as Lonza Group, Samsung Biologics, WuXi AppTec, Catalent, Boehringer Ingelheim, Bayer AG, Regeneron Pharmaceuticals, WuXi Biologics, Pfizer Inc., AbbVie Inc., Roche Holding AG, Novartis International AG, Teva Pharmaceutical Industries Ltd., Amgen Inc., Merck & Co., Inc.